Behavioral, hyperthermic and pharmacokinetic profile of para-methoxymethamphetamine (PMMA) in rats

Pharmacology Biochemistry and Behavior

Volumn 98, Issue 1, 2011, Pages 130-139

  Páleníček, Tomáš ^a   Balíková, Marie ^b   Rohanová, Miroslava ^b   Novák, Tomáš ^a   Horáček, Jiří ^a   Fujáková, Michaela ^a   Höschl, Cyril ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

3,4 methylendioxymethamphetamine (MDMA); Hyperthermia; Locomotion; para methoxyamphetamine (PMA); para methoxymethamphetamine (PMMA); Pharmacokinetics; Prepulse inhibition (PPI); Rats

Indexed keywords

4 METHOXYMETHAMPHETAMINE;

ACOUSTIC REFLEX; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; HYPERTHERMIA; LOCOMOTION; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; TEMPERATURE SENSITIVITY;

ANIMALS; BEHAVIOR, ANIMAL; BODY TEMPERATURE; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEVER; MALE; METHAMPHETAMINE; MODELS, ANIMAL; MOTOR ACTIVITY; PSYCHOTROPIC DRUGS; RATS; RATS, WISTAR; STARTLE REACTION;

RATTUS;

EID: 78651240469     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.12.011     Document Type: Article

References (104)

1. T. Abekawa, T. Ohmori, and T. Koyama Effect of NO synthase inhibition on behavioral changes induced by a single administration of methamphetamine Brain Res 666 1994 147 150
2. U. Antia 'Party pill' drugs - BZP and TFMPP N Z Med J 122 2009 55 68
3. H. Arora, S.M. Owens, and W.B. Gentry Intravenous (+)-methamphetamine causes complex dose-dependent physiologic changes in awake rats Eur J Pharmacol 426 2001 81 87
4. M.V. Bach, R.T. Coutts, and G.B. Baker Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives Xenobiotica 29 1999 719 732
5. K.T. Ball, D. Budreau, and G.V. Rebec Acute effects of 3, 4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors Brain Res 994 2003 203 215
6. M.G. Bankson, and K.A. Cunningham Pharmacological studies of the acute effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors Neuropsychopharmacology 26 2002 40 52
7. J. Becker, P. Neis, J. Rohrich, and S. Zorntlein A fatal paramethoxymethamphetamine intoxication Leg Med (Tokyo) 5 Suppl. 1 2003 S138 S141
8. M. Bossong, T. Brunt, D.J. Van, S. Rigter, J. Hoek, and H. Goldschmidt mCPP: an undesired addition to the ecstasy market J Psychopharmacol 24 2010 1395 1401
9. P.L. Brown, and E.A. Kiyatkin Brain hyperthermia induced by MDMA (ecstasy): modulation by environmental conditions Eur J Neurosci 20 2004 51 58
10. P.L. Brown, R.A. Wise, and E.A. Kiyatkin Brain hyperthermia is induced by methamphetamine and exacerbated by social interaction J Neurosci 23 2003 3924 3929
11. M.J. Bubar, K.M. Pack, P.S. Frankel, and K.A. Cunningham Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA Psychopharmacology (Berl) 173 2004 326 336
12. V. Bubenikova, M. Votava, J. Horacek, and T. Palenicek Relation of sex and estrous phase to deficits in prepulse inhibition of the startle response induced by ecstasy (MDMA) Behav Pharmacol 16 2005 127 130
13. D. Bustamante, G. az-Veliz, C. Paeile, G. Zapata-Torres, and B.K. Cassels Analgesic and behavioral effects of amphetamine enantiomers, p-methoxyamphetamine and n-alkyl-p-methoxyamphetamine derivatives Pharmacol Biochem Behav 79 2004 199 212
14. R.W. Byard, N.G. Rodgers, R.A. James, C. Kostakis, and A.M. Camilleri Death and paramethoxyamphetamine - an evolving problem Med J Aust 176 2002 496
15. P.D. Callaghan, R.J. Irvine, and L.C. Daws Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3, 4-methylenedioxymethamphetamine revealed by chronoamperometry Neurochem Int 47 2005 350 361
16. R.I. Dafters Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing Physiol Behav 58 1995 877 882
17. R. Dams, E.A. De Letter, K.A. Mortier, J.A. Cordonnier, W.E. Lambert, and M.H. Piette Fatality due to combined use of the designer drugs MDMA and PMA: a distribution study J Anal Toxicol 27 2003 318 322
18. A.S. Darvesh, and G.A. Gudelsky Activation of 5-HT2 receptors induces glycogenolysis in the rat brain Eur J Pharmacol 464 2003 135 140
19. L.C. Daws, R.J. Irvine, P.D. Callaghan, N.P. Toop, J.M. White, and F. Bochner Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3, 4-methylenedioxymethamphetamine in the rat Prog Neuropsychopharmacol Biol Psychiatry 24 2000 955 977
20. EMCDDA Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs 2003 European monitoring Centre for Drugs and Drug Addiction (EMCDDA Luxembourg
21. EMCDDA Report on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugs 2004 European monitoring Centre for Drugs and Drug Addiction (EMCDDA Luxembourg
22. R.A. Ener, S.B. Meglathery, W.A. Van Decker, and R.M. Gallagher Serotonin syndrome and other serotonergic disorders Pain Med 4 2003 63 74
23. A. Freezer, A. Salem, and R.J. Irvine Effects of 3, 4- methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide Brain Res 1041 2005 48 55
24. S. Fukushima, H. Shen, H. Hata, A. Ohara, K. Ohmi, and K. Ikeda Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice Psychopharmacology (Berl) 193 2007 55 62
25. W.B. Gentry, A.U. Ghafoor, W.D. Wessinger, E.M. Laurenzana, H.P. Hendrickson, and S.M. Owens (+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration Pharmacol Biochem Behav 79 2004 751 760
26. M.A. Geyer, R.K. Light, G.J. Rose, L.R. Petersen, D.D. Horwitt, and L.M. Adams A characteristic effect of hallucinogens on investigatory responding in rats Psychopharmacology (Berl) 65 1979 35 40
27. M.A. Geyer, K. Krebs-Thomson, D.L. Braff, and N.R. Swerdlow Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review Psychopharmacology (Berl) 156 2001 117 154
28. R.A. Glennon, A.E. Ismaiel, B. Martin, D. Poff, and M. Sutton A preliminary behavioral investigation of PMMA, the 4-methoxy analog of methamphetamine Pharmacol Biochem Behav 31 1988 9 13
29. R.A. Glennon, R. Young, M. Dukat, and Y. Cheng Initial characterization of PMMA as a discriminative stimulus Pharmacol Biochem Behav 57 1997 151 158
30. R.A. Glennon, R. Young, M. Dukat, J. Chang-Fong, and M. El-Zahabi N-Methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA) and N-Methyl-1-(3, 4-methylenedioxyphenyl)-2-aminopropane (MDMA) produce non-identical discriminative stimuli in rats Pharmacol Biochem Behav 86 2007 477 484
31. L.H. Gold, M.A. Geyer, and G.F. Koob Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs NIDA Res Monogr 94 1989 101 126
32. C.J. Gordon, W.P. Watkinson, J.P. O'Callaghan, and D.B. Miller Effects of 3, 4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat Pharmacol Biochem Behav 38 1991 339 344
33. B. Gough, S.Z. Imam, B. Blough, W. Slikker Jr., and S.F. Ali Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study Ann NY Acad Sci 965 2002 410 420
34. A.L. Green, and M.A. El Hait p-Methoxyamphetamine, a potent reversible inhibitor of type-A monoamine oxidase in vitro and in vivo J Pharm Pharmacol 32 1980 262 266
35. A.R. Green, A.J. Cross, and G.M. Goodwin Review of the pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA or "Ecstasy") Psychopharmacology (Berl) 119 1995 247 260
36. A.R. Green, E. O'Shea, and M.I. Colado A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response Eur J Pharmacol 500 2004 3 13
37. D.A. Hall, J.J. Stanis, A.H. Marquez, and J.M. Gulley A comparison of amphetamine- and methamphetamine-induced locomotor activity in rats: evidence for qualitative differences in behavior Psychopharmacology (Berl) 195 2008 469 478
38. P.B. Hedlund, L. Kelly, C. Mazur, T. Lovenberg, J.G. Sutcliffe, and P. Bonaventure 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents Eur J Pharmacol 487 2004 125 132
39. K.M. Hegadoren, M.T. Martin-Iverson, and G.B. Baker Comparative behavioural and neurochemical studies with a psychomotor stimulant, an hallucinogen and 3, 4-methylenedioxy analogues of amphetamine Psychopharmacology (Berl) 118 1995 295 304
40. S. Hjorth Hypothermia in the rat induced by the potent serotoninergic agent 8-OH-DPAT J Neural Transm 61 1985 131 135
41. E.J. Jaehne, A. Salem, and R.J. Irvine Effects of 3, 4- methylenedioxymethamphetamine and related amphetamines on autonomic and behavioral thermoregulation Pharmacol Biochem Behav 81 2005 485 496
42. E.J. Jaehne, A. Salem, and R.J. Irvine Pharmacological and behavioral determinants of cocaine, methamphetamine, 3, 4-methylenedioxymethamphetamine, and para-methoxyamphetamine-induced hyperthermia Psychopharmacology (Berl) 194 2007 41 52
43. S.S. Johansen, A.C. Hansen, I.B. Muller, J.B. Lundemose, and M.B. Franzmann Three fatal cases of PMA and PMMA poisoning in Denmark J Anal Toxicol 27 2003 253 256
44. S. Kaye, S. Darke, and J. Duflou Methylenedioxymethamphetamine (MDMA)-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology Drug Alcohol Depend 104 2009 254 261
45. J.H. Kehne, T.C. McCloskey, V.L. Taylor, C.K. Black, G.M. Fadayel, and C.J. Schmidt Effects of the serotonin releasers 3, 4- methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats J Pharmacol Exp Ther 260 1992 78 89
46. S. Khaliq, B. Irfan, S. Haider, and D.J. Haleem m-CPP induced hypolocomotion does not interfere in the assessment of memory functions in rats Pak J Pharm Sci 21 2008 139 143
47. J.C. Kraner, D.J. McCoy, M.A. Evans, L.E. Evans, and B.J. Sweeney Fatalities caused by the MDMA-related drug paramethoxyamphetamine (PMA) J Anal Toxicol 25 2001 645 648
48. K. Krebs-Thomson, and M.A. Geyer The role of 5-HT(1A) receptors in the locomotor-suppressant effects of LSD: WAY-100635 studies of 8-OH-DPAT, DOI and LSD in rats Behav Pharmacol 7 1996 551 559
49. K. Krebs-Thomson, V. Lehmann-Masten, S. Naiem, M.P. Paulus, and M.A. Geyer Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin Eur J Pharmacol 343 1998 135 143
50. K. Krebs-Thomson, M.P. Paulus, and M.A. Geyer Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors Neuropsychopharmacology 18 1998 339 351
51. K. Krebs-Thomson, E.M. Ruiz, V. Masten, M. Buell, and M.A. Geyer The roles of 5-HT(1A) and 5-HT (2) receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats Psychopharmacology (Berl) 189 2006 319 329
52. O. Ladefoged The effects of LSD, psilocybin, harmaline and amphetamine on the body temperature of para-chlorophenylalanine pretreated rats Arch Int Pharmacodyn Thér 204 1973 326 332
53. P.G. Lamberth, G.K. Ding, and L.A. Nurmi Fatal paramethoxy-amphetamine (PMA) poisoning in the Australian Capital Territory Med J Aust 188 2008 426
54. J. Lát The analysis of habituation Acta Neurobiol Exp (Wars) 33 1973 771 789
55. D.L. Lin, H.C. Liu, and H.L. Yin Recent paramethoxymethamphetamine (PMMA) deaths in Taiwan J Anal Toxicol 31 2007 109 113
56. W. Lindner, and I.W. Wainer Requirements for initial assay validation and publication in J. Chromatography B J Chromatogr B Biomed Sci Appl 707 1998 1 2
57. M.P. Lindquist, and K.G. Gotestam Open-field behavior after intravenous amphetamine analogues in rats Psychopharmacology (Berl) 55 1977 129 133
58. J.E. Lopatka, C.N. Brewerton, D.S. Brooks, D.A. Cook, and D.M. Paton The protective effects of methysergide, 6-hydroxydopamine and other agents on the toxicity of amphetamine, phentermine, MDA, PMA, and STP in mice Res Commun Chem Pathol Pharmacol 14 1976 677 687
59. J.R. Martin, T.M. Ballard, and G.A. Higgins Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety Pharmacol Biochem Behav 71 2002 615 625
60. M.T. Martin-Iverson, N. Yamada, A.W. By, and B.A. Lodge "Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment J Psychiatry Neurosci 16 1991 253 261
61. A.C. McCreary, M.G. Bankson, and K.A. Cunningham Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/ 1D) receptors J Pharmacol Exp Ther 290 1999 965 973
62. H. Mizoguchi, S. Arai, H. Koike, D. Ibi, H. Kamei, and T. Nabeshima Therapeutic potential of nicotine for methamphetamine-induced impairment of sensorimotor gating: involvement of pallidotegmental neurons Psychopharmacology (Berl) 207 2009 235 243
63. B.J. Myles, and K.E. Sabol The effects of methamphetamine on core body temperature in the rat - part 2: an escalating regimen Psychopharmacology (Berl) 198 2008 313 322
64. D.E. Nichols, M. Ilhan, and J.P. Long Comparison of cardiovascular, hyperthermic, and toxic effects of para-methoxyamphetamine (PMA) and 3, 4-methylenedioxyamphetamine (MDA) Arch Int Pharmacodyn Thér 214 1975 133 140
65. E.D. O'Loinsigh, G. Boland, J.P. Kelly, and K.M. O'Boyle Behavioural, hyperthermic and neurotoxic effects of 3, 4-methylenedioxymethamphetamine analogues in the Wistar rat Prog Neuropsychopharmacol Biol Psychiatry 25 2001 621 638
66. Y. Ootsuka, and W.W. Blessing Thermogenesis in brown adipose tissue: increase by 5-HT2A receptor activation and decrease by 5-HT1A receptor activation in conscious rats Neurosci Lett 395 2006 170 174
67. Y. Ootsuka, W.W. Blessing, and E. Nalivaiko Selective blockade of 5-HT2A receptors attenuates the increased temperature response in brown adipose tissue to restraint stress in rats Stress 11 2008 125 133
68. R.A. Padich, T.C. McCloskey, and J.H. Kehne 5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100, 907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats Psychopharmacology (Berl) 124 1996 107 116
69. T. Palenicek, V. Bubenikova, M. Votava, and J. Horacek Účinky MDMA, LSD a psilocinu na lokomoci potkana The effects of MDMA, LSD and Psilocin on locomotion of the rat Adiktologie 5 2005 120 130
70. T. Palenicek, M. Votava, V. Bubenikova, and J. Horacek Increased sensitivity to the acute effects of MDMA ("ecstasy") in female rats Physiol Behav 86 2005 546 553
71. T. Palenicek, M. Fujakova, M. Kutova, M. Brunovsky, J. Horacek, and V. Bubenikova-Valesova Behavioral and QEEG effects of the psychedelic drug 4-bromo-2, 5-dimethoxyphenylethylamine (2C-B) in rats - a possible model of psychosis? Behav Pharmacol 18 2007 S13
72. T. Palenicek, Z. Hlinak, V. Bubenikova-Valesova, M. Votava, and J. Horacek An analysis of spontaneous behavior following acute MDMA treatment in male and female rats Neuro Endocrinol Lett 28 2007 781 788
73. T. Palenicek, M. Balikova, V. Bubenikova-Valesova, and J. Horacek Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose Psychopharmacology (Berl) 196 2008 51 62
74. T. Palenicek, Z. Hlinak, V. Bubenikova-Valesova, T. Novak, and J. Horacek Sex differences in the effects of N, N-diethyllysergamide (LSD) on behavioural activity and prepulse inhibition Prog Neuropsychopharmacol Biol Psychiatry 34 2010 588 596
75. A.C. Parrott Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity Pharmacol Biochem Behav 71 2002 837 844
76. A.C. Parrott Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity Psychopharmacology (Berl) 173 2004 234 241
77. M.P. Paulus, and M.A. Geyer The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity Neuropsychopharmacology 7 1992 15 31
78. J. Penders, and A. Verstraete Laboratory guidelines and standards in clinical and forensic toxicology Accredit Qual Assur 11 2006 284 290
79. F.T. Peters, O.H. Drummer, and F. Musshoff Validation of new methods Forensic Sci Int 165 2007 216 224
80. J.L. Pilgrim, D. Gerostamoulos, O.H. Drummer, and M. Bollmann Involvement of amphetamines in sudden and unexpected death J Forensic Sci 54 2009 478 485
81. M. Rohanova, and M. Balikova Studies on distribution and metabolism of para-methoxymethamphetamine (PMMA) in rats after subcutaneous administration Toxicology 259 2009 61 68
82. C.A. Romero, D.A. Bustamante, G. Zapata-Torres, M. Goiny, B. Cassels, and M. Herrera-Marschitz Neurochemical and behavioural characterisation of alkoxyamphetamine derivatives in rats Neurotox Res 10 2006 11 22
83. D.E. Rusyniak, M.V. Zaretskaia, D.V. Zaretsky, and J.A. DiMicco 3, 4-Methylenedioxymethamphetamine- and 8-hydroxy-2-di-n-propylamino-tetralin- induced hypothermia: role and location of 5-hydroxytryptamine 1A receptors J Pharmacol Exp Ther 323 2007 477 487
84. D.E. Rusyniak, Y. Ootsuka, and W.W. Blessing When administered to rats in a cold environment, 3, 4-methylenedioxymethamphetamine reduces brown adipose tissue thermogenesis and increases tail blood flow: effects of pretreatment with 5-HT1A and dopamine D2 antagonists Neuroscience 154 2008 1619 1626
85. P. Salmi, and S. Ahlenius Evidence for functional interactions between 5-HT1A and 5-HT2A receptors in rat thermoregulatory mechanisms Pharmacol Toxicol 82 1998 122 127
86. A. Satow, G. Suzuki, S. Maehara, H. Hikichi, T. Murai, and T. Murai Unique antipsychotic activities of the selective metabotropic glutamate receptor 1 allosteric antagonist 2-cyclopropyl-5- [1- (2-fluoro-3-pyridinyl) -5-methyl-1H-1, 2, 3-triazol-4-yl] - 2, 3-dihydro-1H-isoindol-1-one J Pharmacol Exp Ther 330 2009 179 190
87. C.J. Schmidt, C.K. Black, G.M. Abbate, and V.L. Taylor Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors Brain Res 529 1990 85 90
88. B. Schutova, L. Hruba, M. Pometlova, and R. Slamberova Impact of prenatal and acute methamphetamine exposure on behaviour of adult male rats Prague Med Rep 110 2009 67 78
89. M.C. Scorza, C. Carrau, R. Silveira, G. Zapata-Torres, B.K. Cassels, and M. Reyes-Parada Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives: structure-activity relationships Biochem Pharmacol 54 1997 1361 1369
90. A. Shulgin, and A. Shulgin PIHKAL : A Chemical Love Story 1991 Transform Press Berkley, CA
91. T.A. Sipes, and M.A. Geyer Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats Neuropharmacology 33 1994 441 448
92. T.E. Sipes, and M.A. Geyer DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT(2A) and not by 5-HT(2C) receptors Behav Pharmacol 6 1995 839 842
93. J.R. Smythies, V.S. Johnston, R.J. Bradley, F. Benington, R.D. Morin, and L.C. Clark Some new behaviour-disrupting amphetamines and their significance Nature 216 1967 128 129
94. R.F. Staack, and H.H. Maurer Metabolism of designer drugs of abuse Curr Drug Metab 6 2005 259 274
95. R.F. Staack, J. Fehn, and H.H. Maurer New designer drug p-methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 789 2003 27 41
96. R.F. Staack, D.S. Theobald, L.D. Paul, D. Springer, T. Kraemer, and H.H. Maurer Identification of human cytochrome P450 2D6 as major enzyme involved in the O-demethylation of the designer drug p-methoxymethamphetamine Drug Metab Dispos 32 2004 379 381
97. N. Stanley, A. Salem, and R.J. Irvine The effects of co-administration of 3, 4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats Neuroscience 146 2007 321 329
98. T.D. Steele, J.L. Katz, and G.A. Ricaurte Evaluation of the neurotoxicity of N-methyl-1- (4-methoxyphenyl) -2-aminopropane (para-methoxymethamphetamine, PMMA) Brain Res 589 1992 349 352
99. E.A. Sykes Mescaline-induced motor impairment in rats, assessed by two different methods Life Sci 39 1986 1051 1058
100. F.X. Vollenweider, and M.A. Geyer A systems model of altered consciousness: integrating natural and drug-induced psychoses Brain Res Bull 56 2001 495 507
101. F.X. Vollenweider, S. Remensberger, D. Hell, and M.A. Geyer Opposite effects of 3, 4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans Psychopharmacology (Berl) 143 1999 365 372
102. M.T. Williams, N.R. Herring, T.L. Schaefer, M.R. Skelton, N.G. Campbell, and J.W. Lipton Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse Neuropsychopharmacology 32 2007 1404 1420
103. I.Q. Wishaw, F. Haun, and B. Kolb Analysis of behavior in laboratory rodents U. Windhorst, H. Johansson, Modern techniques in neuroscience 1999 Springer-Verlag Berlin, Germany 1243 1275
104. R. Young, M. Dukat, L. Malmusi, and R.A. Glennon Stimulus properties of PMMA: effect of optical isomers and conformational restriction Pharmacol Biochem Behav 64 1999 449 453